87306274
Jan 18, 2017
NANT HOLDINGS IP LLC
Subscribe
Promoting collaboration within the scientific, research, pharmaceutical, provider, and payer communities to accelerate the development and use of immunotherapy and genomic sequencing in cancer treatment